{"DataElement":{"publicId":"3269809","version":"1","preferredName":"Biomarker Peroxisome Proliferative Activated Receptor Gamma Testing Not Done Reason Text","preferredDefinition":"Text explanation for why peroxisome proliferative activated receptor gamma (PPARy) testing was not done.","longName":"PPARY_NOT_DN_RSN_TXT","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3269806","version":"1","preferredName":"Biomarker Peroxisome Proliferative Activated Receptor Gamma Testing Not Done Reason","preferredDefinition":"Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc_A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._Expressed as multiple variants in adipose tissue (highest), skeletal muscle, spleen, heart, liver placenta, lung, and ovary by human PPARG Gene (NR1/PPAR Family), nuclear Peroxisome Proliferative Activated Receptor Gamma heterodimerizes with RXRs and NCOA6 coactivator to regulate target gene transcription. A receptor that binds peroxisome proliferators, such as hypolipidemic drugs and fatty acids, PPARG is a key regulator of adipocyte differentiation and glucose homeostasis. Once activated by ligand, PPARG binds to an acyl-CoA oxidase gene promoter element, activates transcription, and controls the peroxisomal fatty acid beta-oxidation pathway. Defects in PPARG can lead to type 2 insulin-resistant diabetes and hypertension. (NCI)_Indicates a task, process or examination that has either not been initiated or completed._An explanation of the cause of some phenomenon or action.","longName":"PPARY_TST_NOT_DN_RSN","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2969417","version":"1","preferredName":"Biomarker Peroxisome Proliferative Activated Receptor Gamma","preferredDefinition":"Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc:Expressed as multiple variants in adipose tissue (highest), skeletal muscle, spleen, heart, liver placenta, lung, and ovary by human PPARG Gene (NR1/PPAR Family), nuclear Peroxisome Proliferative Activated Receptor Gamma heterodimerizes with RXRs and NCOA6 coactivator to regulate target gene transcription. A receptor that binds peroxisome proliferators, such as hypolipidemic drugs and fatty acids, PPARG is a key regulator of adipocyte differentiation and glucose homeostasis. Once activated by ligand, PPARG binds to an acyl-CoA oxidase gene promoter element, activates transcription, and controls the peroxisomal fatty acid beta-oxidation pathway. Defects in PPARG can lead to type 2 insulin-resistant diabetes and hypertension. (NCI)","longName":"C16342:C34077","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Peroxisome Proliferator-Activated Receptor Gamma","conceptCode":"C34077","definition":"Peroxisome proliferator-activated receptor gamma (505 aa, ~58 kDa) is encoded by the human PPARG gene. This protein plays a role in transcriptional regulation, lipid metabolism, cell differentiation, glucose homeostasis and apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AC109C2-2FE5-5C6A-E040-BB89AD4314B5","latestVersionIndicator":"Yes","beginDate":"2009-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-15","modifiedBy":"ONEDATA","dateModified":"2009-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3269804","version":"1","preferredName":"Testing Not Done Reason","preferredDefinition":"A procedure for critical evaluation.:Indicates a task, process or examination that has either not been initiated or completed.:An explanation of the cause of some phenomenon or action.","longName":"C15336:C49484:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testing","conceptCode":"C15336","definition":"A procedure for critical evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC4797E5-0E13-B87C-E040-BB89AD430F29","latestVersionIndicator":"Yes","beginDate":"2011-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-06","modifiedBy":"ONEDATA","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC4797E5-0E24-B87C-E040-BB89AD430F29","latestVersionIndicator":"Yes","beginDate":"2011-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182830","version":"1","preferredName":"Reason Text","preferredDefinition":"A free text field that describes a reason.","longName":"RSN_TXT","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008583","version":"1","preferredName":"Response","preferredDefinition":"a spoken or written statement that is made in reply to a question or request.","longName":"RESPONSE","context":"EDRN","contextVersion":"1","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"CAAB9A16-A8FD-455E-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-10-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2003-10-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D751EFE2-206C-1EAF-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-04-09","modifiedBy":"TITARENKOI","dateModified":"2021-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812571","version":"1","longName":"Lombardi Cancer Center","context":"NCIP"},{"publicId":"2812605","version":"1","longName":"Lombardi New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If No, please explain:","type":"Preferred Question Text","description":"If No, please explain:","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AC46B303-41AA-EC24-E040-BB89AD431A2A","latestVersionIndicator":"Yes","beginDate":"2011-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-06","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeDescription":"Curated to support Lombardi Cancer Center clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}